From “Botox in a bottle” to castor oil and face taping, Dermatology Times reviews the evidence behind 3 viral dermatology ...
Clinician FAQ on remibrutinib's FDA approval in symptomatic dermographism: RemIND efficacy, mechanism, safety, and supporting ...
Find out what skin care products and aesthetic innovations clinicians are recommending to patients for the month of October.
Updated SKYRIZI labeling allows clinicians to use clinical judgment when determining the need for TB evaluation before treatment.
A melanoma expert discusses gaps in dermoscopy education, cognitive bias during skin examinations, and strategies to improve ...
Mark Lebwohl, MD, discusses atopic march data and systemic treatment options for pediatric atopic dermatitis. Mark Lebwohl, ...
Elevate-Derm Summer 2026 faculty share practical lessons on hair loss exams, PIH, geriatric dermatology, and managing cholesterol rises on JAK inhibitors.
At Horizons in Advanced Practice, Douglas DiRuggiero, DMSc, MHS, PA-C, reviewed oral and targeted psoriasis therapies and ...
Menopause can bring dryness, sensitivity, acne, and loss of firmness, requiring dermatologists to adapt skin care to patients ...
Lutikizumab (ABT-981) met its primary end point and all 8 ranked secondary end points in the phase 3 INTREPID trial ...
Aclaris Therapeutics announced positive phase 1b proof-of-concept results for ATI-052, an investigational bispecific antibody ...
At Horizons in Advanced Practice, Evangelia Nezis, NP, shares early results with oral peptides and takeaways on type 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results